Overview: TSH Receptor Antibody TestIntroduction: The TSH Receptor Antibody Test detects TSH receptor antibodies to diagnose Graves' disease, causing weight loss. Aligned with 2023 ATA guidelines, it uses immunoassays for high specificity, supporting hormonal screening. This test is critical for guiding diagnosis, treatment planning, and improving outcomes in immunology for patients with suspected Graves' disease.
Other Names: TSH Receptor Antibody Assay, TRAb Test.
FDA Status: Laboratory-developed test (LDT), meeting immunology standards for diagnostic accuracy.
Historical Milestone: TSH receptor antibody testing began in the 1980s with Graves' disease research. Immunoassay methods improved in the 2000s, enhancing diagnostic precision.
Purpose: Detects TSH receptor antibodies to diagnose Graves' disease, guides treatment, and evaluates patients with weight loss.
Test Parameters: 1. TSH Receptor Antibodies
Pretest Condition: No fasting required. Collect serum or saliva. Report history of weight loss or hyperthyroid symptoms.
Specimen: Serum (SST, 2-5 mL), Saliva (sterile container, 1-2 mL). Transport in a biohazard container.
Sample Stability at Room Temperature: 8 hours
Sample Stability at Refrigeration: 7 days
Sample Stability at Frozen: 6 months
Medical History: Document weight loss, palpitations, or history of Graves' disease. Include current medications, especially antithyroid drugs.
Consent: Written consent required, detailing the tests purpose, Graves' disease implications, and risks of sample collection.
Procedural Considerations: Uses enzyme-linked immunosorbent assay (ELISA) or radioimmunoassay to detect TSH receptor antibodies. Results are available in 1-2 days, supporting clinical decisions. Performed in laboratories, often for Graves' disease diagnosis.
Factors Affecting Result Accuracy: Sample hemolysis or improper storage can affect results. Medications like methimazole may alter antibody levels.
Clinical Significance: Positive TSH receptor antibodies confirm Graves' disease, guiding antithyroid therapy or surgery. Negative results may require TSI or thyroid scan.
Specialist Consultation: Consult an endocrinologist for result interpretation and treatment planning.
Additional Supporting Tests: TSI, thyroid scan, or free T4 to confirm Graves' disease diagnosis.
Test Limitations: Non-specific for other hyperthyroid conditions; clinical correlation is needed. Sample quality affects sensitivity.
References: ATA Thyroid Guidelines, 2023; Journal of Clinical Endocrinology, Kahaly GJ, 2022.
